BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6702257)

  • 41. [Atrial Septal Defect with Hereditary Deficiency of Antithrombin III].
    Naruse H; Sakamoto Y; Kinouchi K; Inoue T; Matsumura Y; Yoshitake M; Bando K; Hashimoto K
    Kyobu Geka; 2016 Jul; 69(7):508-10. PubMed ID: 27365061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
    Werner MJ
    J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombin III concentrates--are they clinically useful?
    Lechner K; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of antithrombin III concentrates to correct antithrombin III deficiency during vascular surgery.
    Jackson MR; Olsen SB; Gomez ER; Alving BM
    J Vasc Surg; 1995 Dec; 22(6):804-7. PubMed ID: 8523616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prophylaxis of thrombosis in a pregnant woman with congenital antithrombin III deficiency: changes in hemostatic molecular markers before the onset of thrombosis].
    Inomoto T; Takamoto M; Horiuchi N; Sato K; Fujino O; Oka K; Tomonari A; Uno Y; Sigekiyo T
    Rinsho Ketsueki; 1992 Sep; 33(9):1166-71. PubMed ID: 1433937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Determination of the necessary time for prevention of thromboembolism using heparin/dihydroergotamine during implantation of partial hip joint endoprostheses].
    Maldini B; Matijasević B
    Acta Chir Iugosl; 1989; 36(1):169-78. PubMed ID: 2711804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Perioperative blood coagulation therapy and diagnosis].
    Kretschmer V
    Infusionstherapie; 1990 Apr; 17 Suppl 2():9-19. PubMed ID: 2197226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Benefits and risks of antithrombin III concentrates].
    Conard J
    Ann Fr Anesth Reanim; 1992; 11(3):330-1. PubMed ID: 1503313
    [No Abstract]   [Full Text] [Related]  

  • 53. Value of thrombin-antithrombin III complexes in major orthopedic surgery: relation to the onset of venous thromboembolism.
    Pazzagli M; Mazzantini D; Cella G; Rampin E; Palla A
    Clin Appl Thromb Hemost; 1999 Oct; 5(4):228-31. PubMed ID: 10726018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.
    Nelson DM; Stempel LE; Brandt JT
    Obstet Gynecol; 1985 Jun; 65(6):848-53. PubMed ID: 4039808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylaxis during surgery in antithrombin III deficiency with low dose of concentrates.
    Blanco AN; Meschengieser S; Penalva LB; Lazzari MA
    Thromb Res; 1989 Nov; 56(3):497-9. PubMed ID: 2617483
    [No Abstract]   [Full Text] [Related]  

  • 59. Lower risk of thromboembolic disease after total hip replacement with non-cemented than with cemented prostheses.
    Francis CW; Marder VJ; Evarts CM
    Lancet; 1986 Apr; 1(8484):769-71. PubMed ID: 2421120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Congenital Antithrombin Deficiency in a Pregnant Woman with Right Atrium Thrombosis.
    Sabzi F; Khosravi D; Faraji R
    Ethiop J Health Sci; 2015 Oct; 25(4):385-9. PubMed ID: 26949306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.